DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for children Dr. Nandita Mohan27 April 2022 5:43 PM ISTThe Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for...
Health Bulletin 27/April/2022 Dr. Nandita Mohan27 April 2022 4:58 PM ISTHere are the top health stories for the day :NMC denies permission to 3 Medical Colleges, 550 MBBS seats lostFinding major deficiencies in three major...
Coronavirus vaccine: DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for different age group of children MD Bureau26 April 2022 5:00 PM ISTDCGI approved restricted use for emergency situation to ZycovD for children above the age of 12 years for a two-dose regimen.
Biological E gets CDSCO panel nod for Corbevax EUA for 5-11 years old Ruchika Sharma22 April 2022 1:10 PM ISTBiological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years.
Biological E new recipient of mRNA technology through WHO technology transfer hub Ruchika Sharma2 April 2022 11:00 AM ISTWHO and partners will work with the Indian government and Bio E to develop a roadmap and put in place the necessary training and support so that the...
COVID vaccine Corbevax to cost Rs 145 for govt, Rs 990 in private market Revu suresh19 March 2022 2:40 PM ISTNew Delhi: The COVID-19 vaccine administered for children aged between 12 and 14 years, Corbevax, is being sold to the government at Rs 145 per dose,...
17/March/2022 Top Health Bulletin Roshni Dhar17 March 2022 6:30 PM ISTHere are top health stories for today: Ukraine Medical Universities To Offer Online Classes Offering hope to thousands of medical...
Biological E seeks EUA for Corbevax for children MD Bureau10 March 2022 5:39 PM ISTCorbevax is India's first indigenously developed Receptor Binding Domain (RBD) Protein sub-unit vaccine against Covid-19.
CDSCO SEC okays Covovax for 12-17 year-olds Medical Dialogues Bureau6 March 2022 5:06 PM ISTNew Delhi: The Subject Expert Committee (SEC) has recommended granting emergency use authorisation (EUA) to Serum India of India's COVID-19 vaccine...
Corbevax gets DCGI emergency use nod for 12-18 age group Roshni Dhar23 Feb 2022 4:12 PM ISTBiological E. Limited has announced that its CORBEVAX vaccine, which is India's first indigenously developed Receptor Binding Domain (RBD) Protein...
Health Bulletin 22/February/2022 Roshni Dhar22 Feb 2022 5:09 PM ISTHere are the Top health stories of the dayMadras HC gives preference to community's Tamil LGBTQIA+ Glossary over state govt's; lauds state govt's...
Biological E Corbevax gets DCGI nod for 12-18 years Ruchika Sharma22 Feb 2022 12:22 PM ISTThe CORBEVAX vaccine is administered through intramuscular route with two doses scheduled 28 days apart.
